Think Bioscience
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Think Bioscience - overview
Established
2019
Location
Boulder, CO, US
Primary Industry
Biotechnology
About
Based in Colorado, US, founded in 2019 and co-founded by its CEO Jerome Fox, Think Bioscience Inc. develops therapeutics medicines by using small molecule therapeutics. In January 2026, Think Bioscience raised USD 55 million in series A funding co-led by Innovation Endeavors and Janus Henderson Investors and Regeneron Ventures, with participation from CE Venture Capital, MBX Capital,YK Bioventures, AV8 Ventures, CU Healthcare Innovation Fund, Buff Gold Ventures. The firm offers a platform that mixes computational biology with biological computation and develops small-molecule therapeutics against elusive targets by applying microbiology, enzymology, and computational science.
The company plans to utilize the January 2026 funding to accelerate its synthetic biology platform and pipeline, enabling access to challenging drug targets.
Current Investors
Innovation Endeavors, Wireframe Ventures, AV8 Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.thinkbioscience.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Think Bioscience - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.